🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of the Location of Motor Cortical Stimulation Electrodes in Chronic Neuropathic Refractory Patients

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier Universitaire de Nice
NCT06216717 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cortical stimulation has been used since 1991 to treat neuropathic pain. However, the underlying mechanisms are still incompletely understood and under-studied. In this protocol, the investigators aim to study the myeloarchitectonic and functional characteristics of areas activated by cortical epidural electrodes and to determine their relation to therapy response in chronic neuropathic refractory pain patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria * adults * patient implanted with a motor cortical stimulation system for chronic neuropathic refractory pain, * patient with available postoperative scanner Exclusion Criteria: None
💊

What it tests

  • Not listed
📍

Where

1 site
CHU NICE
Nice, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy